NFKB1 and Parkinson disease: In conclusion, administration of HE ameliorates neuroinflammation, neurodegeneration, and behavioral defects in a PD mouse model via modulation of NF-κB activity, thus supporting a role for HE as an anti-inflammatory drug for the treatment of PD.